Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Cardiovascular disease news

Show

From To
New drug options, risk factors added to U.S. heart guidelines

Updated U.S. guidelines on heart health advise more personalized assessment of risk as well as two newer types of cholesterol-lowering drugs for people at particularly high risk of heart attack or stroke.

Published
11 November 2018
From
Reuters
Cardiovascular Risk Unclear for HIV Patients on Dolutegravir

Patients with HIV who switched to a dolutegravir-based regimen from a ritonavir-boosted protease inhibitor regimen experienced body mass gain and changes in biomarkers related to increased insulin resistance, according to a subanalysis of the NEAT 022 study.

Published
01 November 2018
From
Medscape (requires free registration)
HIV Does Not Increase Risk of Acute Coronary Syndrome Recurrence

Although previous studies have shown that individuals infected with human immunodeficiency virus (HIV) are at increased risk for acute coronary syndrome (ACS), including myocardial infarction, a new large health care system study has found that they have no greater likelihood of a recurrent episode after hospitalization than uninfected individuals.

Published
10 September 2018
From
MD Magazine
HIV/AIDS research yields dividends across medical fields

Nearly four decades of study has propelled advances in heart disease, hepatitis, cancer and other diseases.

Published
28 August 2018
From
Eurekalert Inf Dis
Many people take drugs that interfere with their blood pressure pills

People who take pills to lower their blood pressure often take other drugs that reduce the pills’ effectiveness, a recent study suggests.

Published
22 August 2018
From
Reuters
Global Burden of HIV-Related CVD Has Tripled Over Two Decades

People with HIV are more than twice as likely to develop cardiovascular disease than those without the virus, according to the results of a new review and meta-analysis.

Published
17 July 2018
From
TCTMD
Cumulative Ritonavir-Boosted Darunavir Use May Be Associated With Increased CVD Risk

In patients infected with HIV, the cumulative use for ritonavir-boosted darunavir was associated with a progressively increasing risk for cardiovascular disease, according to research published in The Lancet HIV.

Published
11 June 2018
From
Infectious Disease Advisor
What's the connection between HIV and high blood pressure?

People with HIV are more likely than people without the virus to have high blood pressure, in part because of treatments and repercussions of the condition itself, a new review of research shows.

Published
23 May 2018
From
American Heart Association News
Increased Risk for Abdominal Obesity Found in People Living With HIV

People living with HIV are at increased risk for abdominal obesity, hypertriglyceridemia, and elevated low-density lipoprotein (LDL) cholesterol but not hypertension, according to a recent study published in Clinical Infectious Diseases.

Published
04 April 2018
From
Infectious Disease Advisor
1 in 8 patients with HIV has undiagnosed hypertension

To estimate the prevalence of hypertension among PLWH, CDC researchers used data from the Medical Monitoring Project, a surveillance system designed to produce nationally representative estimates of behavioral and clinical characteristics of adults infected with HIV in the U.S.

Published
06 February 2018
From
Healio
← First12345...13Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.